S100A9 and acute kidney injury: In clinical studies on patients (including pediatric patients) with acute kidney injury (AKI), DAMPs, specifically S100A8/S100A9 and urine mitochondrial DNA (mtDNA), have been identified as potential diagnostic and prognostic biomarkers, reflecting, for example, the severity of this disease (115–117).